PCSK9 and metabolic syndrome: Finally, in patients with stable CVD, low PCSK9 plasma levels were associated with a metabolic pattern characterized by low HDL cholesterol, the metabolic syndrome, elevated BMI, insulin resistance and diabetes with diffuse non-obstructive coronary atherosclerosis [67].